| Outcome | Apixaban (n = 314) |
Warfarin (n = 785) |
P value |
|---|---|---|---|
| Recurrent VTE, n (%) | 14 (4.5) | 68 (8.7) | .02 |
| Major bleeding, n (%) | 12 (3.8) | 26 (3.3) | .72 |
| CRNM bleeding, n (%) | 4 (1.3) | 24 (3.1) | .14 |
| All-cause mortality, n (%) | 13 (4.1) | 18 (2.3) | .11 |
| Switch in anticoagulation, n (%) | 18 (5.8) | 63 (8.3) | .20 |
| Hospital encounters, mean ± SD | 2.9 ± 4.3 | 6.6 ± 9.2 | <.01 |
Please use landscape view or desktop screen to view the content.
Incidence of Recurrent VTE, Major Bleeding, CRNM Bleeding, All-Cause Mortality, Switch in Anticoagulation, and Hospital Encounters1
Crouch 2022
